{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T06:55:00Z","timestamp":1778655300669,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T00:00:00Z","timestamp":1625616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T00:00:00Z","timestamp":1625616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The present study was supported by CAMS Innovation Fund for Medical Sciences","award":["CIFMS, No. 2016-I2M-1-018"],"award-info":[{"award-number":["CIFMS, No. 2016-I2M-1-018"]}]},{"name":"Youth Innovation Project of Sichuan Provincial Medical Association","award":["Q17087"],"award-info":[{"award-number":["Q17087"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["3332018125"],"award-info":[{"award-number":["3332018125"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatitis E virus (HEV) is a nonenveloped RNA virus causing hepatitis E worldwide. The increase in transfusion-transmitted cases of HEV infections from asymptomatic blood donors causing serious illnesses among immunosuppressed recipients has been reported in the past few years. China is one of the most prevalent regions of HEV; as a result, it is important to evaluate the risk of transfusion-transmitted HEV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 1864 serum samples (including demographic characteristics) from blood donors were randomly collected from February to March 2018 in Dali city. Anti-HEV IgG, IgM and IgA antibodies and HEV antigen were examined by enzyme-linked immunosorbent assay (ELISA). HEV RNA was detected by real-time PCR. Multivariable logistic regression modelling was used to examine the risk factors associated with HEV prevalence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, the positive rates of anti-HEV IgG, IgM, and IgA antibodies were 13.36% (249\/1864), 1.13% (21\/1864), and 1.82% (34\/1864), respectively. However, none of the 1864 serum samples were HEV antigen positive or HEV RNA positive. Females (16.69%) had a significantly higher HEV seroprevalence than males (13.04%) (odds ratio [OR] 1.34 [95% CI, 1.02\u20131.75]). Bai (18.85%) donors had a significantly higher HEV seroprevalence than Han (12.21%) blood donors (odds ratio [OR], 1.65 [95% CI, 1.24\u20132.19] for Bai).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HEV showed a seroprevalence among blood donors in Yunnan Province, some of which were even recent infections, indicating a threat to the safety of blood transfusions. Whether to formulate a strategy for HEV screening in blood centres needs further research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12985-021-01607-y","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T07:02:53Z","timestamp":1625641373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Hepatitis E virus prevalence among blood donors in Dali, China"],"prefix":"10.1186","volume":"18","author":[{"given":"Ping","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baochai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianfu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue\u2019e","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lishan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiancheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6919-3742","authenticated-orcid":false,"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,7]]},"reference":[{"key":"1607_CR1","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/hep.25505","volume":"55","author":"DB Rein","year":"2012","unstructured":"Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology. 2012;55:988\u201397.","journal-title":"Hepatology"},{"key":"1607_CR2","unstructured":"Hepatitis E. https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/hepatitis-e. Accessed 10 Oct 2019."},{"issue":"Suppl 3","key":"1607_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/BF02779283","volume":"26","author":"H Zhuang","year":"1991","unstructured":"Zhuang H, Cao XY, Liu CB, Wang GM. Epidemiology of hepatitis E in China. Gastroenterol Jpn. 1991;26(Suppl 3):135\u20138.","journal-title":"Gastroenterol Jpn"},{"key":"1607_CR4","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3201\/eid2006.140140","volume":"20","author":"PC Woo","year":"2014","unstructured":"Woo PC, Lau SK, Teng JL, Tsang AK, Joseph M, Wong EY, Tang Y, Sivakumar S, Xie J, Bai R, et al. New hepatitis E virus genotype in camels, the Middle East. Emerg Infect Dis. 2014;20:1044\u20138.","journal-title":"Emerg Infect Dis"},{"key":"1607_CR5","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/S0140-6736(14)61034-5","volume":"384","author":"PE Hewitt","year":"2014","unstructured":"Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S, Haywood B, Kennedy IT, Kitchen A, Patel P, Poh J, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet. 2014;384:1766\u201373.","journal-title":"Lancet"},{"key":"1607_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1423-0410.2011.01583.x","volume":"103","author":"SA Baylis","year":"2012","unstructured":"Baylis SA, G\u00e4rtner T, Nick S, Ovemyr J, Bl\u00fcmel J. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang. 2012;103:89\u201390.","journal-title":"Vox Sang"},{"key":"1607_CR7","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/trf.12929","volume":"55","author":"S Sauleda","year":"2015","unstructured":"Sauleda S, Ong E, Bes M, Janssen A, Cory R, Babizki M, Shin T, Lindquist A, Hoang A, Vang L, et al. Seroprevalence of hepatitis E virus (HEV) and detection of HEV RNA with a transcription-mediated amplification assay in blood donors from Catalonia (Spain). Transfusion. 2015;55:972\u20139.","journal-title":"Transfusion"},{"key":"1607_CR8","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/trf.13402","volume":"56","author":"BM Hogema","year":"2016","unstructured":"Hogema BM, Molier M, Sjerps M, de Waal M, van Swieten P, van de Laar T, Molenaar-de Backer M, Zaaijer HL. Incidence and duration of hepatitis E virus infection in Dutch blood donors. Transfusion. 2016;56:722\u20138.","journal-title":"Transfusion"},{"key":"1607_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/trf.12121","volume":"54","author":"D Juhl","year":"2014","unstructured":"Juhl D, Baylis SA, Bl\u00fcmel J, G\u00f6rg S, Hennig H. Seroprevalence and incidence of hepatitis E virus infection in German blood donors. Transfusion. 2014;54:49\u201356.","journal-title":"Transfusion"},{"key":"1607_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jhep.2018.02.031","volume":"69","author":"D Westh\u00f6lter","year":"2018","unstructured":"Westh\u00f6lter D, Hiller J, Denzer U, Polywka S, Ayuk F, Rybczynski M, Horvatits T, Gundlach S, Bl\u00f6cker J, Schulze Zur Wiesch J, et al. HEV-positive blood donations represent a relevant infection risk for immunosuppressed recipients. J Hepatol. 2018;69:36\u201342.","journal-title":"J Hepatol"},{"key":"1607_CR11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1423-0410.2010.01412.x","volume":"100","author":"MA Beale","year":"2011","unstructured":"Beale MA, Tettmar K, Szypulska R, Tedder RS, Ijaz S. Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors? Vox Sang. 2011;100:340\u20132.","journal-title":"Vox Sang"},{"key":"1607_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/trf.13976","volume":"57","author":"RS Tedder","year":"2017","unstructured":"Tedder RS, Ijaz S, Kitchen A, Ushiro-Lumb I, Tettmar KI, Hewitt P, Andrews N. Hepatitis E risks: pigs or blood-that is the question. Transfusion. 2017;57:267\u201372.","journal-title":"Transfusion"},{"key":"1607_CR13","doi-asserted-by":"publisher","first-page":"1700616","DOI":"10.2807\/1560-7917.ES.2018.23.35.1700616","volume":"23","author":"C Niederhauser","year":"2018","unstructured":"Niederhauser C, Widmer N, Hotz M, Tinguely C, Fontana S, Allemann G, Borri M, Infanti L, Sarraj A, Sigle J, et al. Current hepatitis E virus seroprevalence in Swiss blood donors and apparent decline from 1997 to 2016. Euro Surveill. 2018;23:1700616.","journal-title":"Euro Surveill"},{"key":"1607_CR14","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S1995-7645(14)60160-7","volume":"7","author":"LJ Li","year":"2014","unstructured":"Li LJ, Shen YY, Ai ZQ, Guo L, Geng CR. Seroepidemiology and genetic characterization of hepatitis E virus in western Yunnan Province. Asian Pac J Trop Med. 2014;7:909\u201312.","journal-title":"Asian Pac J Trop Med"},{"key":"1607_CR15","doi-asserted-by":"publisher","first-page":"12999","DOI":"10.1128\/JVI.79.20.12999-13006.2005","volume":"79","author":"TC Li","year":"2005","unstructured":"Li TC, Takeda N, Miyamura T, Matsuura Y, Wang JC, Engvall H, Hammar L, Xing L, Cheng RH. Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus. J Virol. 2005;79:12999\u20133006.","journal-title":"J Virol"},{"key":"1607_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jviromet.2005.07.004","volume":"131","author":"N Jothikumar","year":"2006","unstructured":"Jothikumar N, Cromeans TL, Robertson BH, Meng XJ, Hill VR. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J Virol Methods. 2006;131:65\u201371.","journal-title":"J Virol Methods"},{"key":"1607_CR17","doi-asserted-by":"publisher","first-page":"e0161089","DOI":"10.1371\/journal.pone.0161089","volume":"11","author":"M Wang","year":"2016","unstructured":"Wang M, Fu P, Yin Y, He M, Liu Y. Acute, recent and past HEV infection among voluntary blood donors in China: a systematic review and meta-analysis. PLoS ONE. 2016;11:e0161089.","journal-title":"PLoS ONE"},{"key":"1607_CR18","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/trf.12530","volume":"54","author":"F Ren","year":"2014","unstructured":"Ren F, Zhao C, Wang L, Wang Z, Gong X, Song M, Zhuang H, Huang Y, Shan H, Wang J, et al. Hepatitis E virus seroprevalence and molecular study among blood donors in China. Transfusion. 2014;54:910\u20137.","journal-title":"Transfusion"},{"key":"1607_CR19","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1053\/j.gastro.2011.02.050","volume":"140","author":"N Kamar","year":"2011","unstructured":"Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, Dumortier J, Cannesson A, Cassuto-Viguier E, Thervet E, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology. 2011;140:1481\u20139.","journal-title":"Gastroenterology"},{"key":"1607_CR20","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/jmv.1890400414","volume":"40","author":"KH Chau","year":"1993","unstructured":"Chau KH, Dawson GJ, Bile KM, Magnius LO, Sjogren MH, Mushahwar IK. Detection of IgA class antibody to hepatitis E virus in serum samples from patients with hepatitis E virus infection. J Med Virol. 1993;40:334\u20138.","journal-title":"J Med Virol"},{"key":"1607_CR21","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.dld.2016.01.007","volume":"48","author":"G Ricco","year":"2016","unstructured":"Ricco G, Bonino F, Lanza M, Scatena F, Alfieri CM, Messa P, Marchisio E, Mascolo G, Roman\u00f2 L, Galli C, et al. New immunoassays for total, IgA and IgM antibodies against hepatitis E virus: prevalence in Italian blood donors and patients with chronic liver or kidney diseases. Dig Liver Dis. 2016;48:536\u201341.","journal-title":"Dig Liver Dis"},{"key":"1607_CR22","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1007\/s10620-008-0657-4","volume":"54","author":"S Zhang","year":"2009","unstructured":"Zhang S, Tian D, Zhang Z, Xiong J, Yuan Q, Ge S, Zhang J, Xia N. Clinical significance of anti-HEV IgA in diagnosis of acute genotype 4 hepatitis E virus infection negative for anti-HEV IgM. Dig Dis Sci. 2009;54:2512\u20138.","journal-title":"Dig Dis Sci"},{"key":"1607_CR23","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.3201\/eid2011.140516","volume":"20","author":"P Gallian","year":"2014","unstructured":"Gallian P, Lhomme S, Piquet Y, Saun\u00e9 K, Abravanel F, Assal A, Tiberghien P, Izopet J. Hepatitis E virus infections in blood donors, France. Emerg Infect Dis. 2014;20:1914\u20137.","journal-title":"Emerg Infect Dis"},{"key":"1607_CR24","doi-asserted-by":"publisher","first-page":"20550","DOI":"10.2807\/1560-7917.ES2013.18.31.20550","volume":"18","author":"E Slot","year":"2013","unstructured":"Slot E, Hogema BM, Riezebos-Brilman A, Kok TM, Molier M, Zaaijer HL. Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill. 2013;18:20550.","journal-title":"Euro Surveill"},{"key":"1607_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1128\/JCM.40.1.117-122.2002","volume":"40","author":"XJ Meng","year":"2002","unstructured":"Meng XJ, Wiseman B, Elvinger F, Guenette DK, Toth TE, Engle RE, Emerson SU, Purcell RH. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol. 2002;40:117\u201322.","journal-title":"J Clin Microbiol"},{"key":"1607_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/vox.12846","volume":"115","author":"WC Tsoi","year":"2020","unstructured":"Tsoi WC, Zhu X, To AP, Holmberg J. Hepatitis E virus infection in Hong Kong blood donors. Vox Sang. 2020;115:11\u20137.","journal-title":"Vox Sang"},{"key":"1607_CR27","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/hep.28668","volume":"64","author":"F Huang","year":"2016","unstructured":"Huang F, Li Y, Yu W, Jing S, Wang J, Long F, He Z, Yang C, Bi Y, Cao W, et al. Excretion of infectious hepatitis E virus into milk in cows imposes high risks of zoonosis. Hepatology. 2016;64:350\u20139.","journal-title":"Hepatology"},{"key":"1607_CR28","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1056\/NEJMra1204512","volume":"367","author":"JH Hoofnagle","year":"2012","unstructured":"Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. N Engl J Med. 2012;367:1237\u201344.","journal-title":"N Engl J Med"},{"key":"1607_CR29","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/tan.12007","volume":"80","author":"Y Yao","year":"2012","unstructured":"Yao Y, Shi L, Tao Y, Kulski JK, Lin K, Huang X, Xiang H, Chu J, Shi L. Distinct HLA allele and haplotype distributions in four ethnic groups of China. Tissue Antigens. 2012;80:452\u201361.","journal-title":"Tissue Antigens"},{"key":"1607_CR30","doi-asserted-by":"publisher","first-page":"27341","DOI":"10.1371\/journal.pone.0027341","volume":"6","author":"H Lou","year":"2011","unstructured":"Lou H, Li S, Yang Y, Kang L, Zhang X, Jin W, Wu B, Jin L, Xu S. A map of copy number variations in Chinese populations. PLoS ONE. 2011;6:27341.","journal-title":"PLoS ONE"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-021-01607-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-021-01607-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-021-01607-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T07:07:11Z","timestamp":1625641631000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-021-01607-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1607"],"URL":"https:\/\/doi.org\/10.1186\/s12985-021-01607-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-118265\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-118265\/v1","asserted-by":"object"}]},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,7]]},"assertion":[{"value":"26 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committees of the Institute of Blood Transfusion, Chinese Academy of Medical Sciences (IBT).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}